Is it acceptable to run a sponsor investigator clinical trial at multiple unrelated clinical sites?
To put it another way, is it acceptable to have multiple 1572's in a sponsor investigator clinical trial? My sense is that it would not be acceptable but I am hoping for a reality check.
Further, is it acceptable to list individuals from multiple clinical sites as sub-investigators on a 1572? I doubt this would be acceptable as well.
Thanks in advance,
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
firstname.lastname@example.org+1 301 770 2920
JoinMy RAPS DashboardLearn More